Michael Nally, Chief Executive Officer at Generate Biomedicines, Inc. (GENB), bought 20,000 shares at $12.00 ($240K) on 2026-03-04, disclosed to the SEC on 2026-03-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.